7Baggers
 published on: 2025-11-16 05:42:52  newser.com Sun, 16 Nov 2025 11:42:52 GMT
 published on: 2025-11-13 18:12:20  newser.com Fri, 14 Nov 2025 00:12:20 GMT
 published on: 2025-11-13 04:06:38  newser.com Thu, 13 Nov 2025 10:06:38 GMT
 published on: 2025-11-10 20:35:06  newser.com Tue, 11 Nov 2025 02:35:06 GMT
 rallybio swings to profit and gains years of breathing room  Finimize Fri, 07 Nov 2025 20:59:02 GMT
 rallybio corporation reports strong q3 2025 results  TipRanks Fri, 07 Nov 2025 05:54:52 GMT
 Rallybio Swings To Profit And Gains Years Of Breathing Room  Finimize Thu, 06 Nov 2025 21:21:40 GMT
 new haven biotech rallybio posts quarterly profit after asset sale  Hartford Business Journal Thu, 06 Nov 2025 14:39:58 GMT
 Rallybio Corp SEC 10-Q Report  TradingView Thu, 06 Nov 2025 13:23:00 GMT
 Biotech firm Rallybio's Q3 net income $16 mln, reverses prior loss  TradingView Thu, 06 Nov 2025 13:07:41 GMT
 Rallybio Corporation Reports Strong Q3 2025 Results  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 published on: 2025-11-05 22:36:04  newser.com Thu, 06 Nov 2025 04:36:04 GMT
 published on: 2025-11-05 21:40:29  newser.com Thu, 06 Nov 2025 03:40:29 GMT
 published on: 2025-11-05 21:37:51  newser.com Thu, 06 Nov 2025 03:37:51 GMT
 published on: 2025-11-04 00:27:08  newser.com Tue, 04 Nov 2025 06:27:08 GMT

Rallybio Corporation
(NASDAQ:RLYB) 

RLYB stock logo

Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead program is RLYB212, a preclinical-stage monoclonal anti-HPA-1a antibody for t...

Founded: 2018
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends